Prognosis
Danish Shot Gets EU Nod for Monkeypox as WHO Declares Emergency
- Bavarian Nordic’s smallpox vaccine gets extended label
- Stock gains as much as 10% as analysts see demand surging
This article is for subscribers only.
A little-known Danish drugmaker won formal approval in the European Union for its vaccine against monkeypox as the World Health Organization declared the outbreak a global health emergency.
Bavarian Nordic A/S’s smallpox vaccine Imvanex got permission to be labeled for monkeypox and another disease caused by the vaccinia virus, the Danish vaccine maker said Monday. The label extension comes after similar clearances in Canada and the US. The stock rose as much as 10% in Copenhagen trading.